To make National Institute of Pathology a premier research Institute by carrying out research in molecular pathology, genetics, immunodiagnostics, vaccine development, environmental bio-monitoring and applied fields for better health care. Efforts are being made to bring new technologies to the Institute, viz.: proteomics, nanotechnology, stem cell, tissue microarray, image analysis, etc. It is envisaged to establish Institute as a resource center for Modern Pathology and Biotechnology both nationally and internationally. In looking to the future and taking into account the past output from National Institute of Pathology, new high priority areas for research have been identified, viz.: metabolic syndromes (diabetes, CAD, obesity), chronic diseases biology (fibrosis liver/ lung/ pancreas), idiopathic skin diseases (psoriasis, vitiligo) and bioinformatics alongwith continuation of working in existing thrust areas of tumor biology, infectious diseases, adult stem cell biology and environmental toxicology. It is envisaged that National Institute of Pathology should emerge as a Center of Excellence for Research, Training and Reference for Medical and Biomedical Sciences catering to health problems of national importance. Efforts are underway to establish a biobank for the pathologically characterized surgical material. Telepathology is being established in an effort to establish network with pathologists at different medical colleges and health centers.